CV Sciences, Inc.|4Apr 1, 8:22 PM ET

Grasser Joerg 4

4 · CV Sciences, Inc. · Filed Apr 1, 2022

Form 4

Period: 2022-03-30

Chief Financial Officer

Transactions

Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−250,000→ 0 total
Exercise: $0.66Exp: 2029-03-14→ Common Stock (250,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−750,000→ 0 total
Exercise: $0.59Exp: 2031-03-08→ Common Stock (750,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−250,000→ 0 total
Exercise: $0.66Exp: 2028-12-25→ Common Stock (250,000 underlying)
Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−750,000→ 0 total
Exercise: $0.33Exp: 2030-03-19→ Common Stock (750,000 underlying)

Footnotes (3)

[F1]The option is durational based. 375,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date.
[F2]On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.
[F3]The option is durational based. All option shares were vested and exercisable on the date of cancellation.

Documents

1 file